Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis


Autoria(s): SA, Vanessa K. de; CANAVEZ, Flavio C.; SILVA, Iran A.; Srougi, Miguel; LEITE, Katia R. M.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

Introduction: Hyaluronidases (HAases) are enzymes related to cancer progression. Isoforms of HAases have been described as products of alternative splicing responsible for differences in enzyme activity. The heterogeneity of HAase expression has been identified in tumors and could be related to the differences in their biological behavior. Methods: Thirty-seven patients subjected to radical prostatectomy for prostate cancer were divided into 2 groups for the analyses: Low (<= 6-18) and high (>= 7-19) Gleason score and tumor behavior; recurrence 15 and nonrecurrence 22, mean follow-up 52.6 months. Conclusion: A profile of HAase related to low Gleason score and non-tumor recurrence was characterized by expression of HYAL3-v1, HYAL1-v3, and HYAL3-v2. More studies should be made in order to confirm with larger series. (C) 2009 Elsevier Inc. All rights reserved.

Identificador

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, v.27, n.4, p.377-381, 2009

1078-1439

http://producao.usp.br/handle/BDPI/23271

10.1016/j.urolonc.2008.04.013

http://dx.doi.org/10.1016/j.urolonc.2008.04.013

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE INC

Relação

Urologic Oncology-seminars and Original Investigations

Direitos

restrictedAccess

Copyright ELSEVIER SCIENCE INC

Palavras-Chave #Hyaluronidases #Hyaluronan #Alternative splicing #Prostate cancer #Prognosis #CELL LUNG-CANCER #MESSENGER-RNA #EXPRESSION #ACID #ANGIOGENESIS #MARKERS #GROWTH #HYAL1 #Oncology #Urology & Nephrology
Tipo

article

original article

publishedVersion